YieldMax MRNA Option Income Strategy ETF (MRNY)
YieldMax MRNA Option Income Strategy ETF operates in the Asset Management - Income industry of the Financial Services sector, headquartered in Los Angeles, CA, US. The stock last traded at $15.95, up 3.50% on the session, giving a market capitalisation of $118.1M. Its beta of -0.09 implies it has historically moved less than the broad market.
This actively managed exchange-traded fund, known as the YieldMax MRNA Option Income Strategy ETF (MRNY), is engineered to deliver consistent weekly income. It achieves this by strategically issuing call options or initiating call spreads that are tied to shares of MRNA. The fundamental design of this approach is to collect premiums from these options, while also providing investors with a means to participate in any upward movement in MRNA's stock valuation.
YieldMax MRNA Option Income Strategy ETF is most often compared with the following Financial Services names: